This company listing is no longer active
2OW Stock Overview
Operates as a medical device company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Silk Road Medical, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.70 |
| 52 Week High | US$8.80 |
| 52 Week Low | US$7.25 |
| Beta | 1.45 |
| 1 Month Change | 0% |
| 3 Month Change | 12.26% |
| 1 Year Change | n/a |
| 3 Year Change | -80.75% |
| 5 Year Change | n/a |
| Change since IPO | -71.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2OW | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -2.8% |
| 1Y | n/a | -14.3% | 10.0% |
Return vs Industry: Insufficient data to determine how 2OW performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 2OW performed against the German Market.
Price Volatility
| 2OW volatility | |
|---|---|
| 2OW Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: 2OW has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2OW's volatility change over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 414 | Chas McKhann | silkroadmed.com |
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure.
Silk Road Medical, Inc Fundamentals Summary
| 2OW fundamental statistics | |
|---|---|
| Market cap | €628.03m |
| Earnings (TTM) | -€51.03m |
| Revenue (TTM) | €156.68m |
4.0x
P/S Ratio-12.3x
P/E RatioIs 2OW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2OW income statement (TTM) | |
|---|---|
| Revenue | US$169.94m |
| Cost of Revenue | US$48.56m |
| Gross Profit | US$121.38m |
| Other Expenses | US$176.72m |
| Earnings | -US$55.35m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 28, 2024
| Earnings per share (EPS) | -1.42 |
| Gross Margin | 71.43% |
| Net Profit Margin | -32.57% |
| Debt/Equity Ratio | 49.2% |
How did 2OW perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/28 01:45 |
| End of Day Share Price | 2023/12/01 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Silk Road Medical, Inc is covered by 9 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Joanne Wuensch | BMO Capital Markets Equity Research |
| Travis Steed | BofA Global Research |